IRD

Opus GeneticsF

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

AI scenario view

RankAlpha Sentiment AI

B+

Bull case

20%

Probability

Target price

$2.91

Analysis reference price unavailable

Analysis 2025-09-29 · RankAlpha Sentiment AI

Most likely

Base case

60%

Probability

Target price

$1.82

Analysis reference price unavailable

Analysis 2025-09-29 · RankAlpha Sentiment AI

B-

Bear case

20%

Probability

Target price

$0.91

Analysis reference price unavailable

Analysis 2025-09-29 · RankAlpha Sentiment AI

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2025-09-29

AI commentary

Market sentiment appears cautious-to-neutral with emphasis on near-term financing and clinical/data catalysts; press and market threads highlight liquidity concerns alongside optimism for platform potential [#yfinance]. Recent coverage and chatter focus on fundraising and partnership expectations rather than broad institutional conviction [#news].

RankAlpha Sentiment AI - 2025-09-29

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

No AI events listed.

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2025-09-29 • Updated nightlySource: Internal modelMethodology